These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7572796)

  • 1. Heparin contamination in coagulation testing and a protocol to avoid it and the risk of inappropriate FFP transfusion.
    Newman RS; Fagin AR
    Am J Clin Pathol; 1995 Oct; 104(4):447-9. PubMed ID: 7572796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multicentric evaluation of heparinase on aPTT, thrombin clotting time and a new PT reagent based on recombinant human tissue factor.
    Harenberg J; Reichel T; Malsch R; Hirsh J; Rustagi P
    Blood Coagul Fibrinolysis; 1996 Jun; 7(4):453-8. PubMed ID: 8839997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enzymatic elimination of heparin from plasma for activated partial thromboplastin time and prothrombin time testing.
    van den Besselaar AM; Meeuwisse-Braun J
    Blood Coagul Fibrinolysis; 1993 Aug; 4(4):635-8. PubMed ID: 8218862
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of coagulation during cardiopulmonary bypass with a heparinase-modified thromboelastographic assay.
    Tuman KJ; McCarthy RJ; Djuric M; Rizzo V; Ivankovich AD
    J Cardiothorac Vasc Anesth; 1994 Apr; 8(2):144-9. PubMed ID: 8204806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin degradation by a novel microbial heparinase.
    Böhmer LH; Pitout MJ; Allcock JL; Visser L
    Thromb Res; 1990 Nov; 60(4):331-5. PubMed ID: 2087692
    [No Abstract]   [Full Text] [Related]  

  • 6. Establishing a new target range for unfractionated heparin for acute coronary syndromes.
    Lee MS; Menon V; Schappert J; Wilentz JR; Singh V; Hochman JS
    J Thromb Thrombolysis; 2004 Apr; 17(2):121-6. PubMed ID: 15306747
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heparinase: in vivo activity and immunogenicity in rabbits.
    Klein MD; Drongowski RA; Linhardt RJ; Cooney CL; Langer RS
    J Lab Clin Med; 1983 Nov; 102(5):828-37. PubMed ID: 6631173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Measurement of the activated partial thromboplastin time from a capillary (fingerstick) sample of whole blood. A new method for monitoring heparin therapy.
    Ansell J; Tiarks C; Hirsh J; McGehee W; Adler D; Weibert R
    Am J Clin Pathol; 1991 Feb; 95(2):222-7. PubMed ID: 1992612
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro reversal of heparin effect with heparinase: evaluation with whole blood prothrombin time and activated partial thromboplastin time in cardiac surgical patients.
    Despotis GJ; Summerfield AL; Joist JH; Goodnough LT; Santoro SA; Zimmermann JJ; Lappas DG
    Anesth Analg; 1994 Oct; 79(4):670-4. PubMed ID: 7943773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of an automated coagulation analyzer to perform heparin neutralization with polybrene in blood samples for routine coagulation testing: practical, rapid, and inexpensive.
    Tientadakul P; Kongkan C; Chinswangwatanakul W
    Arch Pathol Lab Med; 2013 Nov; 137(11):1641-7. PubMed ID: 24168503
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of heparin concentration and activated clotting time monitoring on blood conservation. A prospective, randomized evaluation in patients undergoing cardiac operation.
    Despotis GJ; Joist JH; Hogue CW; Alsoufiev A; Kater K; Goodnough LT; Santoro SA; Spitznagel E; Rosenblum M; Lappas DG
    J Thorac Cardiovasc Surg; 1995 Jul; 110(1):46-54. PubMed ID: 7609568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monitoring heparin therapy by the activated partial thromboplastin time--the effect of pre-analytical conditions.
    van den Besselaar AM; Meeuwisse-Braun J; Jansen-Grüter R; Bertina RM
    Thromb Haemost; 1987 Apr; 57(2):226-31. PubMed ID: 3603414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Removal of the anticoagulant activities of the low molecular weight heparin fractions and fragments with flavobacterial heparinase.
    Yang VC; Bernstein H; Cooney CL; Kadam JC; Langer R
    Thromb Res; 1986 Dec; 44(5):599-610. PubMed ID: 3810562
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of heparinase to neutralize residual heparin in blood samples drawn through pediatric indwelling central venous catheters.
    Keller FG; DeFazio J; Jencks F; Steiner M; Rogers J; Ritchey AK
    J Pediatr; 1998 Jan; 132(1):165-7. PubMed ID: 9470022
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The PiCT
    Brisset AC; Ferrández A; Krause M; Rathbun S; Marlar R; Korte W
    J Thromb Haemost; 2016 Nov; 14(11):2187-2193. PubMed ID: 27582411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heparin monitoring by activated partial thromboplastin time. Comparison of ex vivo measurement and in vitro standardization.
    Scialla SJ
    Am J Clin Pathol; 1985 Sep; 84(3):351-4. PubMed ID: 4036867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated activated partial thromboplastin time does not correlate with heparin rebound following cardiac surgery.
    Taneja R; Marwaha G; Sinha P; Quantz M; Stitt L; Gao R; Subramanian S; Schaus M; Keeney M; Chin-Yee I; Murkin J
    Can J Anaesth; 2009 Jul; 56(7):489-96. PubMed ID: 19408066
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Variability in heparin sensitivity of APTT reagents.
    Bjornsson TD; Nash PV
    Am J Clin Pathol; 1986 Aug; 86(2):199-204. PubMed ID: 3739971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How to Optimize Activated Partial Thromboplastin Time (APTT) Testing: Solutions to Establishing and Verifying Normal Reference Intervals and Assessing APTT Reagents for Sensitivity to Heparin, Lupus Anticoagulant, and Clotting Factors.
    Favaloro EJ; Kershaw G; Mohammed S; Lippi G
    Semin Thromb Hemost; 2019 Feb; 45(1):22-35. PubMed ID: 30630206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of undiagnosed coagulopathies using routine rapid heparin neutralization.
    Burns ER; Lee V; Wenz B
    Clin Lab Sci; 1995; 8(2):113-6. PubMed ID: 10150468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.